Many guidelines recommend a peripheral and central blood culture in febrile children with cancer, although data on the utility of the former are scarce. We aimed to report the prevalence and predictors of bacteremia in this cohort, and the utility of a peripheral blood culture in identifying missed bacterial infections. This was a single-center, retrospective study of febrile children with cancer. Between 2014 and 2018, we compared the group with at least one positive blood culture to the group without. We identified 342 unique febrile visits with a mean age of 7.6 years. Fifteen (4%) had bacteremia: 1 only peripheral, 11 only central, 3 both peripheral and central. The odds of bacteremia increased with reinduction chemotherapy (adjusted odds ratio [aOR] = 4.68 [1.13-19.42]) and decreased in children older than 3 years (aOR = 0.27 [0.09-0.80]). In conclusion, our rates of bacteremia were low and the utility of peripheral blood cultures was limited.
SalstromJLCoughlinRLPoolK, et al. Pediatric patients who receive antibiotics for fever and neutropenia in less than 60 min have decreased intensive care needs. Pediatr Blood Cancer. 2015;62(5):807-815.
2.
FreifeldAGBowEJSepkowitzKA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56-e93.
DagherGASafaRHajjarK, et al. Characteristics and outcomes of pediatric septic patients with cancer: a retrospective cohort study. J Emerg Med. 2019;57(2):216-226.
5.
ElioCFontanaVIlariaC, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296-1304.
6.
DoganisDAsmarBYankelevichMThomasRRavindranathY.Predictive factors for blood stream infections in children with cancer. Pediatr Hematol Oncol J. 2013;30(5):403-415.
7.
RoguinAKasisIBen-ArushMWSharonRBerantM.Fever and neutropenia in children with malignant disease. Pediatr Hematol Oncol J. 1996;13(6):503-510.
8.
DuffyEARabatinM.Preventing central line-associated bloodstream infection in pediatric oncology care. AACN Adv Crit Care. 2018;29(2):111-114.
9.
UllmanAJMarshNMihalaGCookeMRickardCM.Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331-e1344.
10.
MoskalewiczRLIsenalumheLLLuuCWeeCPNagerAL.Bacteremia in nonneutropenic pediatric oncology patients with central venous catheters in the ED. Am J Emerg Med. 2017;35(1):20-24.
11.
RickardCMUllmanAJ.Bloodstream infection and occlusion of central venous catheters in children. Lancet Infect Dis. 2018;18(8):815-817.
12.
RodriguezLEthierMCPhillipsBLehrnbecherTDoyleJSungL.Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review. Support Care Cancer. 2012;20(12):3261-3267.
MermelLAAllonMBouzaE, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
15.
HandrupMMMollerJKRutkjaerCSchroderH.Importance of blood cultures from peripheral veins in pediatric patients with cancer and a central venous line. Pediatr Blood Cancer. 2015;62(1):99-102.
16.
GaurAHFlynnPMHeineDJGianniniMAShenepJLHaydenRT.Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J. 2005;24(5):445-449.
17.
LehrnbecherTRobinsonPDAmmannRA, et al. Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023;41(9):1774-1785.
18.
CheaitoRTamimHEl KebbiO, et al. Urine testing for the detection of urinary tract infections in febrile pediatric cancer patients presenting to the ED. Health Care: Curr Rev. 2022;10:1-8.
19.
KlasterskyJde NauroisJRolstonK, et al. Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol. 2016;27(suppl 5):v111-v118.
20.
FlowersCRSeidenfeldJBowEJ, et al. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013;31(6):794-810.
21.
SchwartzbergLS.Neutropenia: etiology and pathogenesis. Clin Cornerstone. 2006;8suppl 5:S5-S11.
22.
GoldsteinBGiroirBRandolphA; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2-8.
23.
BonafideCPBradyPWKerenR, et al. Development of heart and respiratory rate percentile curves for hospitalized children. Pediatrics. 2013;131:e1150-e1157.
24.
LimaMAFde Sá RodriguesKEVanucciMF, et al. Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy. Hematol Transfus Cell Ther. 2023;45(2):170-175.
25.
HaeuslerGMThurskyKASlavinMA, et al. Risk stratification in children with cancer and febrile neutropenia: a national, prospective, multicentre validation of nine clinical decision rules. EClinicalMedicine. 2020;18:100220.
26.
EsbenshadeAJPentimaMCZhaoZ, et al. Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer. Pediatr Blood Cancer. 2015;62(2):262-268.
27.
KaraSSTezerHPolatM, et al. Risk factors for bacteremia in children with febrile neutropenia. Turk J Med Sci. 2019;49(4):1198-1205.
28.
KimY-HLeeH-DHahJ-O.Bacteremia in pediatric cancer patients: causative organisms and antibiotic sensitivities. Korean J Pediatr. 2005;48(6):619-623.
29.
InabaHPeiDWolfJ, et al. Infection-related complications during treatment for childhood acute lymphoblastic leukemia. Ann Oncol. 2017;28(2):386-392.
30.
EllisM.Febrile neutropenia. Ann N Y Acad Sci. 2008;1138(1):329-350.
